feed,title,long_url,short_url
Benzinga,"February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More",https://benzinga.com/general/biotech/23/01/30648889/february-pdufa-catalysts-biotech-investors-must-know-sanofis-bleeding-disorder-drug-regenerons-tw,https://da.gd/P94A
Benzinga,Want Better Execution On Options Trades? Interactive Brokers Has You Covered With One New Feature,https://benzinga.com/fintech/23/01/30649125/want-better-execution-on-options-trades-interactive-brokers-has-you-covered-with-one-new-feature,https://da.gd/Mr963f
